The implantable medical devices market size has grown strongly in recent years. It will grow from $109.97 billion in 2025 to $117.13 billion in 2026 at a compound annual growth rate (CAGR) of 6.5%. The growth in the historic period can be attributed to limited availability of advanced implant materials, reliance on conventional metallic and polymer implants, growing prevalence of cardiovascular and orthopedic disorders, increasing surgical procedures in hospitals, awareness of implant-based therapies.
The implantable medical devices market size is expected to see strong growth in the next few years. It will grow to $148.87 billion in 2030 at a compound annual growth rate (CAGR) of 6.2%. The growth in the forecast period can be attributed to development of bioresorbable and smart implants, rising demand for customized and patient-specific implants, growth in minimally invasive surgical techniques, expansion of cochlear and neural interface implants, integration of ai and digital monitoring technologies. Major trends in the forecast period include rising adoption of cardiovascular and orthopedic implants, increasing demand for minimally invasive implant procedures, growth in personalized and customizable implants, expansion of neurostimulator and drug delivery implant usage, enhanced regulatory compliance and safety standards.
The growing demand for minimally invasive surgical procedures is expected to drive the expansion of the implantable medical devices market in the coming years. Minimally invasive procedures are medical interventions conducted through small incisions or openings, which help minimize patient trauma and recovery time. This demand is rising due to the benefits such procedures offer, including quicker recovery, lower risk of complications, reduced pain, and smaller scars, making them more attractive to patients seeking safer and faster treatment options. Implantable medical devices play a crucial role in these procedures by facilitating targeted therapy delivery and real-time monitoring. They contribute to faster healing, decreased complication risks, and improved long-term outcomes through precise and personalized interventions. For example, in November 2024, the American Society of Plastic Surgeons, a U.S.-based non-profit organization, reported that the total number of cosmetic minimally invasive procedures reached 25,442,640 in 2023, reflecting a 7% rise from 23,672,269 in 2022. Thus, the increasing demand for minimally invasive surgical procedures is fueling the growth of the implantable medical devices market.
Leading companies in the implantable medical devices market are prioritizing the development of advanced technologies and obtaining regulatory approvals, such as those in the field of bioelectric medicine, to improve treatment effectiveness, minimize side effects, and deliver personalized, minimally invasive therapeutic options. Bioelectric medicine involves the use of electrical signals to diagnose, treat, or stimulate the nervous system to enhance health and manage various conditions. For example, in July 2023, Boston Scientific Corporation, a biotechnology company based in the U.S., received approval from the U.S. Food and Drug Administration (FDA) for its Vercise Neural Navigator 5 Software. When used in conjunction with the Vercise Genus deep brain stimulation (DBS) systems, this software offers clinicians straightforward and actionable data for efficient programming in the treatment of patients with Parkinson’s disease or essential tremor. It allows for more flexible programming, enabling customized treatment plans tailored to each patient’s specific symptoms and requirements.
In November 2024, Boston Scientific Corporation, a medical device company based in the U.S., acquired Axonics Inc. for approximately $3.7 billion. Through this acquisition, Boston Scientific seeks to strengthen its urology and pelvic health portfolio by incorporating Axonics’ advanced sacral neuromodulation systems and Bulkamid urethral bulking agent, thereby providing improved treatment options for patients suffering from urinary and bowel dysfunction. Axonics Inc. is a U.S.-based medical technology firm specializing in implantable devices designed to treat urinary and bowel disorders.
Major companies operating in the implantable medical devices market are Johnson & Johnson, Abbott Laboratories, Medtronic plc, Stryker Corporation, Boston Scientific Corporation, Alcon Inc., Zimmer Biomet Holdings Inc., Terumo Corporation, Terumo Medical Corporation, Smith & Nephew plc, W. L. Gore & Associates Inc., Edwards Lifesciences Corporation, Dentsply Sirona Inc., Demant A S, Institut Straumann AG, Biotronik SE & Co. KG, Integra LifeSciences Holdings Corporation, Globus Medical Inc., LivaNova Public Limited Company, MicroPort Scientific Corporation, B. Braun Melsungen Aktiengesellschaft, Cochlear Limited.
North America was the largest region in the implantable medical devices market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the implantable medical devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the implantable medical devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs are impacting the implantable medical devices market by increasing the cost of imported raw materials such as titanium, ceramics, and advanced polymers. Segments like orthopedic implants, cardiovascular devices, and microchip implants are most affected, with Asia-Pacific regions including China and India facing higher import duties. This has led to increased manufacturing costs and supply chain challenges. On the positive side, tariffs are encouraging local production, technological innovation, and investment in domestic manufacturing capabilities.
The implantable medical devices market research report is one of a series of new reports that provides implantable medical devices market statistics, including implantable medical devices industry global market size, regional shares, competitors with a implantable medical devices market share, detailed implantable medical devices market segments, market trends and opportunities, and any further data you may need to thrive in the implantable medical devices industry. This implantable medical devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Implantable medical devices are instruments or apparatuses surgically inserted into the human body to monitor, support, or replace a biological function. These devices are intended to stay inside the body for extended durations, either temporarily or permanently, to assist in diagnosing, treating, or managing various medical conditions.
The primary types of implantable medical devices include cardiovascular implants, orthopedic implants, ophthalmology implants, dental implants, cochlear implants, microchip implants, and others. Cardiovascular implants are devices surgically placed to support, repair, or replace parts of the heart or blood vessels, such as stents, pacemakers, or artificial valves. These implants can be made from various biomaterials including ceramics, metals, polymers, and natural substances, and are used by end users like hospitals, ambulatory surgical centers, multi-specialty centers, clinics, and more.
The implantable medical devices market consists of sales of diagnostic implants, therapeutic implants, monitoring implants, and mechanical implants. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
The implantable medical devices market size is expected to see strong growth in the next few years. It will grow to $148.87 billion in 2030 at a compound annual growth rate (CAGR) of 6.2%. The growth in the forecast period can be attributed to development of bioresorbable and smart implants, rising demand for customized and patient-specific implants, growth in minimally invasive surgical techniques, expansion of cochlear and neural interface implants, integration of ai and digital monitoring technologies. Major trends in the forecast period include rising adoption of cardiovascular and orthopedic implants, increasing demand for minimally invasive implant procedures, growth in personalized and customizable implants, expansion of neurostimulator and drug delivery implant usage, enhanced regulatory compliance and safety standards.
The growing demand for minimally invasive surgical procedures is expected to drive the expansion of the implantable medical devices market in the coming years. Minimally invasive procedures are medical interventions conducted through small incisions or openings, which help minimize patient trauma and recovery time. This demand is rising due to the benefits such procedures offer, including quicker recovery, lower risk of complications, reduced pain, and smaller scars, making them more attractive to patients seeking safer and faster treatment options. Implantable medical devices play a crucial role in these procedures by facilitating targeted therapy delivery and real-time monitoring. They contribute to faster healing, decreased complication risks, and improved long-term outcomes through precise and personalized interventions. For example, in November 2024, the American Society of Plastic Surgeons, a U.S.-based non-profit organization, reported that the total number of cosmetic minimally invasive procedures reached 25,442,640 in 2023, reflecting a 7% rise from 23,672,269 in 2022. Thus, the increasing demand for minimally invasive surgical procedures is fueling the growth of the implantable medical devices market.
Leading companies in the implantable medical devices market are prioritizing the development of advanced technologies and obtaining regulatory approvals, such as those in the field of bioelectric medicine, to improve treatment effectiveness, minimize side effects, and deliver personalized, minimally invasive therapeutic options. Bioelectric medicine involves the use of electrical signals to diagnose, treat, or stimulate the nervous system to enhance health and manage various conditions. For example, in July 2023, Boston Scientific Corporation, a biotechnology company based in the U.S., received approval from the U.S. Food and Drug Administration (FDA) for its Vercise Neural Navigator 5 Software. When used in conjunction with the Vercise Genus deep brain stimulation (DBS) systems, this software offers clinicians straightforward and actionable data for efficient programming in the treatment of patients with Parkinson’s disease or essential tremor. It allows for more flexible programming, enabling customized treatment plans tailored to each patient’s specific symptoms and requirements.
In November 2024, Boston Scientific Corporation, a medical device company based in the U.S., acquired Axonics Inc. for approximately $3.7 billion. Through this acquisition, Boston Scientific seeks to strengthen its urology and pelvic health portfolio by incorporating Axonics’ advanced sacral neuromodulation systems and Bulkamid urethral bulking agent, thereby providing improved treatment options for patients suffering from urinary and bowel dysfunction. Axonics Inc. is a U.S.-based medical technology firm specializing in implantable devices designed to treat urinary and bowel disorders.
Major companies operating in the implantable medical devices market are Johnson & Johnson, Abbott Laboratories, Medtronic plc, Stryker Corporation, Boston Scientific Corporation, Alcon Inc., Zimmer Biomet Holdings Inc., Terumo Corporation, Terumo Medical Corporation, Smith & Nephew plc, W. L. Gore & Associates Inc., Edwards Lifesciences Corporation, Dentsply Sirona Inc., Demant A S, Institut Straumann AG, Biotronik SE & Co. KG, Integra LifeSciences Holdings Corporation, Globus Medical Inc., LivaNova Public Limited Company, MicroPort Scientific Corporation, B. Braun Melsungen Aktiengesellschaft, Cochlear Limited.
North America was the largest region in the implantable medical devices market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the implantable medical devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the implantable medical devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs are impacting the implantable medical devices market by increasing the cost of imported raw materials such as titanium, ceramics, and advanced polymers. Segments like orthopedic implants, cardiovascular devices, and microchip implants are most affected, with Asia-Pacific regions including China and India facing higher import duties. This has led to increased manufacturing costs and supply chain challenges. On the positive side, tariffs are encouraging local production, technological innovation, and investment in domestic manufacturing capabilities.
The implantable medical devices market research report is one of a series of new reports that provides implantable medical devices market statistics, including implantable medical devices industry global market size, regional shares, competitors with a implantable medical devices market share, detailed implantable medical devices market segments, market trends and opportunities, and any further data you may need to thrive in the implantable medical devices industry. This implantable medical devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Implantable medical devices are instruments or apparatuses surgically inserted into the human body to monitor, support, or replace a biological function. These devices are intended to stay inside the body for extended durations, either temporarily or permanently, to assist in diagnosing, treating, or managing various medical conditions.
The primary types of implantable medical devices include cardiovascular implants, orthopedic implants, ophthalmology implants, dental implants, cochlear implants, microchip implants, and others. Cardiovascular implants are devices surgically placed to support, repair, or replace parts of the heart or blood vessels, such as stents, pacemakers, or artificial valves. These implants can be made from various biomaterials including ceramics, metals, polymers, and natural substances, and are used by end users like hospitals, ambulatory surgical centers, multi-specialty centers, clinics, and more.
The implantable medical devices market consists of sales of diagnostic implants, therapeutic implants, monitoring implants, and mechanical implants. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
Table of Contents
1. Executive Summary
2. Implantable Medical Devices Market Characteristics
3. Implantable Medical Devices Market Supply Chain Analysis
4. Global Implantable Medical Devices Market Trends and Strategies
5. Implantable Medical Devices Market Analysis of End Use Industries
7. Global Implantable Medical Devices Strategic Analysis Framework, Current Market Size, Market Comparisons and Growth Rate Analysis
8. Global Implantable Medical Devices Total Addressable Market (TAM) Analysis for the Market
9. Implantable Medical Devices Market Segmentation
10. Implantable Medical Devices Market Regional and Country Analysis
11. Asia-Pacific Implantable Medical Devices Market
12. China Implantable Medical Devices Market
13. India Implantable Medical Devices Market
14. Japan Implantable Medical Devices Market
15. Australia Implantable Medical Devices Market
16. Indonesia Implantable Medical Devices Market
17. South Korea Implantable Medical Devices Market
18. Taiwan Implantable Medical Devices Market
19. South East Asia Implantable Medical Devices Market
20. Western Europe Implantable Medical Devices Market
21. UK Implantable Medical Devices Market
22. Germany Implantable Medical Devices Market
23. France Implantable Medical Devices Market
24. Italy Implantable Medical Devices Market
25. Spain Implantable Medical Devices Market
26. Eastern Europe Implantable Medical Devices Market
27. Russia Implantable Medical Devices Market
28. North America Implantable Medical Devices Market
29. USA Implantable Medical Devices Market
30. Canada Implantable Medical Devices Market
31. South America Implantable Medical Devices Market
32. Brazil Implantable Medical Devices Market
33. Middle East Implantable Medical Devices Market
34. Africa Implantable Medical Devices Market
36. Implantable Medical Devices Market Competitive Landscape and Company Profiles
37. Implantable Medical Devices Market Other Major and Innovative Companies
40. Implantable Medical Devices Market High Potential Countries, Segments and Strategies
41. Appendix
List of Tables
Executive Summary
Implantable Medical Devices Market Global Report 2026 provides strategists, marketers and senior management with the critical information they need to assess the market.This report focuses implantable medical devices market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase:
- Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
- Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on end user analysis.
- Benchmark performance against key competitors based on market share, innovation, and brand strength.
- Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
- Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
- Report will be updated with the latest data and delivered to you along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Description
Where is the largest and fastest growing market for implantable medical devices? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The implantable medical devices market global report answers all these questions and many more.The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
- The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
- The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
- The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
- The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
- The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
- Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.
Report Scope
Markets Covered:
1) By Product Type: Cardiovascular Implants; Orthopedic Implants; Ophthalmology Implants; Dental Implants; Cochlear Implants; Microchip Implants; Other Product Types2) By Biomaterial: Ceramic; Metallic; Polymers; Natural
3) By End Use: Hospitals; Ambulatory Surgical Centers; Multi-Specialty Centers; Clinics; Other End Uses
Subsegments:
1) By Cardiovascular Implants: Pacemakers; Implantable Cardioverter Defibrillators; Stents; Heart Valves; Cardiac Resynchronization Therapy Devices2) By Orthopedic Implants: Hip Implants; Knee Implants; Spinal Implants; Shoulder Implants; Trauma Implants
3) By Ophthalmology Implants: Intraocular Lenses; Glaucoma Drainage Implants; Corneal Implants; Retinal Implants
4) By Dental Implants: Endosteal Implants; Subperiosteal Implants; Zygomatic Implants; Mini Dental Implants
5) By Cochlear Implants: Unilateral Cochlear Implants; Bilateral Cochlear Implants
6) By Microchip Implants: Radiofrequency Identification Implants; Biosensor Microchips; Neural Interface Microchips
7) By Other Product Types: Neurostimulators; Contraceptive Implants; Drug Delivery Implants; Breast Implants; Penile Implants
Companies Mentioned: Johnson & Johnson; Abbott Laboratories; Medtronic plc; Stryker Corporation; Boston Scientific Corporation; Alcon Inc.; Zimmer Biomet Holdings Inc.; Terumo Corporation; Terumo Medical Corporation; Smith & Nephew plc; W. L. Gore & Associates Inc.; Edwards Lifesciences Corporation; Dentsply Sirona Inc.; Demant A S; Institut Straumann AG; Biotronik SE & Co. KG; Integra LifeSciences Holdings Corporation; Globus Medical Inc.; LivaNova Public Limited Company; MicroPort Scientific Corporation; B. Braun Melsungen Aktiengesellschaft; Cochlear Limited
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita.
Data Segmentation: Country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: Word, PDF or Interactive Report + Excel Dashboard
Added Benefits:
- Bi-Annual Data Update
- Customisation
- Expert Consultant Support
Companies Mentioned
The companies featured in this Implantable Medical Devices market report include:- Johnson & Johnson
- Abbott Laboratories
- Medtronic plc
- Stryker Corporation
- Boston Scientific Corporation
- Alcon Inc.
- Zimmer Biomet Holdings Inc.
- Terumo Corporation
- Terumo Medical Corporation
- Smith & Nephew plc
- W. L. Gore & Associates Inc.
- Edwards Lifesciences Corporation
- Dentsply Sirona Inc.
- Demant A S
- Institut Straumann AG
- Biotronik SE & Co. KG
- Integra LifeSciences Holdings Corporation
- Globus Medical Inc.
- LivaNova Public Limited Company
- MicroPort Scientific Corporation
- B. Braun Melsungen Aktiengesellschaft
- Cochlear Limited
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 250 |
| Published | February 2026 |
| Forecast Period | 2026 - 2030 |
| Estimated Market Value ( USD | $ 117.13 Billion |
| Forecasted Market Value ( USD | $ 148.87 Billion |
| Compound Annual Growth Rate | 6.2% |
| Regions Covered | Global |
| No. of Companies Mentioned | 23 |
